News

Objectives Infliximab, an anti-TNF agent, is used to treat sarcoidosis that does not respond to corticosteroids or second-line agents. The efficacy of other anti-TNF agents, non-TNF biologics and ...
Both regulatory-approved and pipeline treatments for moderate to severe hidradenitis suppurativa demonstrate comparable ...
Sonelokimab, adalimumab, lutikizumab, and bimekizumab are the top-rated treatments for moderate-to-severe HS, a network ...
Scientists have developed a new molecule that boosts hard drive storage capacity by 100 times, a path toward ultra-compact data solutions.
Breakthrough Molecule Magnet Tech Opens Door To 100X HDD Storage Uplift by Zak Killian — Thursday, June 26, 2025, 04:30 PM EDT Comments ...
The new data were collected to fulfill the FDA's requirements to designate adalimumab-fkjp (Hulio) as interchangeable with Humira, enhancing access to affordable biologics for chronic plaque psoriasis ...
Succinate dehydrogenase (SDH) is an ideal fungicidal target. Here, a three-dimensional quantitative structure–activity relationship (3D-QSAR) was established based on the data of 74 compounds with ...
Herein, the binding dynamic parameters between CD44 and HA containing various disaccharide units were analyzed at the single-molecule level. Then, the clustering effect induced by HA containing ...